RuNAway Disease: A two cycle model for transmissible

T J Gibson1

  • 1European Molecular Biology Laboratory, Postfach 10.2209, 69012 Heidelberg, Germany. Toby.Gibson@EMBL-Heidelberg.de

Genome Biology
|August 28, 2001
PubMed
Abstract

Insights

A novel RuNAway scheme proposes parasitic gene proliferation, not prions, causes spongiform encephalopathies (TSEs). This model explains TSEs

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • The agent responsible for transmissible spongiform encephalopathies (TSEs) remains unidentified despite extensive research.
  • The dominant prion hypothesis posits that misfolded host PrP protein (PrPSc) is the infectious agent, explaining the lack of immune response in TSEs.
  • However, prion transmission has not been experimentally verified due to the inability to isolate pure PrPSc aggregates, and evidence suggests infectious agents may not correlate with PrPSc presence.

Purpose of the Study:

  • To propose a novel mechanism, termed RuNAway, for the pathogenesis of TSEs.
  • To investigate the role of uncontrolled proliferation of small dispersed repeat sequences (SINEs) in somatic cells as a potential cause of TSEs.
  • To explain the characteristic long incubation periods and shorter disease progression observed in TSEs.

Main Methods:

  • The study proposes a theoretical model, RuNAway, involving positive feedback loops.
  • The model focuses on the uncontrolled proliferation of SINEs in somatic cells.
  • It postulates that triggering a second feedback loop leads to pathogenic consequences.

Main Results:

  • The RuNAway model suggests that SINE proliferation can induce PrP overproduction, leading to pathogenic effects.
  • This mechanism provides a potential explanation for the observed characteristics of TSEs, including long latency periods.
  • The model is consistent with findings such as PrP0/0 knockout mice being able to transmit TSE agents despite being resistant to the disease itself.

Conclusions:

  • The RuNAway scheme offers an alternative hypothesis for TSE pathogenesis, shifting focus from prions to parasitic gene elements.
  • This model may reconcile conflicting observations in the field, such as the genetic behavior of TSE agents and their apparent decoupling from PrPSc levels.
  • Further research is needed to experimentally validate the RuNAway mechanism and its implications for understanding and potentially treating TSEs.

Related Concept Videos

Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Translesion DNA Polymerases02:10

Translesion DNA Polymerases

Translesion (TLS) polymerases rescue stalled DNA polymerases at sites of damaged bases by replacing the replicative polymerase and installing a nucleotide across the damaged site. Doing so, TLS allows additional time for the cell to repair the damage before resuming regular DNA replication.
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
Toxoplasmosis01:28

Toxoplasmosis

Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
LTR Retrotransposons03:08

LTR Retrotransposons

LTR retrotransposons are class I transposable elements with long terminal repeats flanking an internal coding region. These elements are less abundant in mammals compared to other class I transposable elements. About 8 percent of human genomic DNA comprises LTR retrotransposons. Some of the common examples of LTR retrotransposons are Ty elements in yeast and Copia elements in Drosophila.
The internal coding region of LTR retrotransposons and their mechanism of transposition closely resembles a...